Integrative Health Solutions logoIntegrative HealthSOLUTIONS

Healthy Aging & Longevity

Sermorelin

A short-acting GHRH analog and the longest-established growth hormone secretagogue in clinical use.

Man using a rowing machine in a bright studio
Format
15mg vial — 3mg/mL, 5mL injectable
Price
$240 per vial
Route
Injectable
Evidence level
Moderate
Regulatory status
Compounded
Testing
Baseline Labs Generally Required

Pricing reflects the compounded preparation and doctor review. Final therapy and dosing are determined only after your intake is reviewed.

Overview

Understanding Sermorelin

What is Sermorelin?

Sermorelin is a 29-amino-acid fragment representing the biologically active portion of growth hormone-releasing hormone. Its short half-life produces a pulse closer to natural physiology than longer-acting analogs.

Format & administration

Nightly subcutaneous injection before bed. Sermorelin is frequently the entry protocol for patients new to growth hormone support.

Testing posture

Your doctor determines the final testing requirements for Sermorelin after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.

How it works

How Sermorelin works

  1. 01Sermorelin stimulates pituitary GHRH receptors to release endogenous growth hormone.
  2. 02Because pituitary feedback remains intact, the resulting release stays within the body's own regulatory limits.
Show illustration: Sermorelin
Sermorelin: proposed mechanism, physiology, and reported clinical effects. Educational illustration — not a treatment guarantee.

What has been studied

Potential applications and evidence

These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.

Explored for body composition and lean mass
Discussed for sleep quality and recovery
Potential support for energy and vitality
Often a starting point before longer-acting analogs

Doctor-guided

A personalized approach

Your doctor determines the final testing requirements for Sermorelin after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.

Bloodwork status: Baseline Labs Generally Required

Commonly reviewed at baseline

  • IGF-1
  • Comprehensive metabolic panel (CMP)
  • Fasting glucose and A1c
  • Lipid panel
  • Thyroid panel (TSH, free T4)

Follow-up & monitoring

IGF-1 is typically rechecked at 8 to 12 weeks with fasting glucose, and dosing is titrated from there.

Medication review

Your doctor reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.

Format & dosing

Nightly subcutaneous injection before bed. Sermorelin is frequently the entry protocol for patients new to growth hormone support.

Safety

What patients should know

  • Compounded, not FDA-approved. Not appropriate with active malignancy. Injection-site reactions are the most commonly reported effect.

Who may not be a candidate

  • Pregnancy or nursing
  • Active malignancy without oncology clearance
  • Known hypersensitivity to the preparation
  • Active pituitary disease

Regulatory status: Compounded. Evidence level: Moderate. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed doctor after review of your history.

Common questions

Frequently asked questions

Ready when you are

Find out what your body is actually asking for.

Fill out a short intake form and our care team will build a plan grounded in your labs — not a guess from a supplement aisle.